Unlabeled Drug Samples and the Learned Intermediary: The Case for Drug Company Liability without Preemption

Authors

Susan Poser, University of Nebraska - LincolnFollow

Date of this Version

2007

Comments

Published in Food and Drug Law Journal (2007) 62(4): 653-694. Copyright 2007, Food and Drug Law Institute. Used by permission.

Abstract

Discusses unlabeled drug samples and the learned intermediary. Presents the case for drug company liability without preemption.